The 32 references in paper V. Moroz V., A. Golubev M., A. Kuzovlev N., V. Pisarev M, S. Polovnikov G, A. Shabanov K, M. Golubev A., В. Мороз В, А. Голубев М, А. Кузовлев Н, В. Писарев М, С. Половников Г., А. Шабанов К, М. Голубев А. (2013) “Сурфактантный протеин А (SP-A) — прогностический молекулярный биомаркер при остром респираторном дистресс-синдроме // Surfactant Protein A (SP-A) is a Prognostic Molecular Biomarker in Acute Respiratory Distress Syndrome” / spz:neicon:reanimatology:132

1
Мороз В.В., Голубев А.М.Классификация острого респираторного дистресс-синдрома. Общая реаниматология.2007; 3 (5—6): 7—9.
(check this in PDF content)
2
Мороз В.В., Голубев А.М.Принципы диагностики ранних проявлений острого повреждения легких. Общая реаниматология.2006; 2 (4): 5—7.
(check this in PDF content)
3
Мороз В.В., Власенко А.В., Голубев А.М., Яковлев В.Н., Алексеев В.Г., Булатов Н.Н., Смелая Т.В.Патогенез и дифференциальная диагностика острого респираторного дистресс-синдрома, обусловленного прямыми и непрямыми этиологическими факторами. Общая реа8 ниматология.2011; 7 (3): 5—13.
(check this in PDF content)
4
Мороз В.В., Власенко А.В., Голубев А.М., Яковлев В.Н., Алексеев В.Г., Булатов Н.Н., Смелая Т.В.Дифференцированное лечение острого респираторного дистресс-синдрома, обусловленного прямыми и непрямыми этиологическими факторами. Общая реаниматология. 2011; 7 (4): 5—15.
(check this in PDF content)
5
Голубев А.М., Мороз В.В., Сундуков Д.В.Патогенез острого респираторного дистресс-синдрома. Общая реаниматология.2012; 8 (4): 13—22.
(check this in PDF content)
6
Кузовлев А.Н., Мороз В.В., Голубев А.М., Половников С.Г., Смелая Т.В. Диагностика острого респираторного дистресс-синдрома при нозокомиальной пневмонии. Общая реаниматология.2009; 5 (6): 5—12.
(check this in PDF content)
7
Марченков Ю.В., Власенко А.В., Мороз В.В., Яковлев В.Н.Эволюция диагностики и лечения острого респираторного дистресс-синдрома на основе новейших медицинских технологий. Общая реанимато8 логия.2012; 8 (4): 22—30.
(check this in PDF content)
8
Кузьков В.В., Киров М.Ю.Инвазивный мониторинг гемодинамики в интенсивной терапии и анестезиологии. Архангельск: Правда Севера; 2008.
(check this in PDF content)
9
Flori H.R., Ware L.B., Glidden D., Matthay M.A.Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation. Pediatr. Crit. Care Med.2003; 4 (3): 315–321.
(check this in PDF content)
10
Parsons P.E., Eisner M.D., Thompson B.T., Matthay M.A., Ancukiewicz M., Bernard G.R., Wheeler A.P.; NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit. Care Med.2005; 33(1): 1–6.
(check this in PDF content)
11
Agrawal A., Zhuo H., Brady S., Levitt J., Steingrub J., Siegel M.D., Soto G., Peterson M.W., Chesnutt M.S., Matthay M.A., Liu K.D. Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials. Am. J. Physiol. Lung Cell Mol. Physiol.2012; 303 (8): L634—L639.
(check this in PDF content)
12
Ware L.B., Matthay M.A., Parsons P.E., Thompson B.T., Januzzi J.L., Eisner M.D.; The National Heart, Lung and Blood Institute ARDS Clinical Trials Network.Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit. Care Med.2007; 35 (8): 1821–1828.
(check this in PDF content)
13
Suratt B.T., Eisner M.D., Calfee C.S., Allard J.B., Whittaker L.A., Engelken D.T., Petty J.M., Trimarchi T., Gauthier L., Parsons P.E. Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injury. Crit. Care Med.2009; 37 (4): 1322—1328.
(check this in PDF content)
14
Proudfoot A., Hind M., Griffiths M.Biomarkers of acute lung injury: worth their salt? BMC Med.2011; 9: 132—140.
(check this in PDF content)
15
Гриппи М.Патофизиология легких. М.: БИНОМ; 2001.
(check this in PDF content)
16
Ware L., Koyama T., Billheimer D., Wu W., Bernard G., Thompson B., Brower R., Standiford T., Martin T., Matthay M.Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest.2010; 137 (2): 288—296.
(check this in PDF content)
17
Galsser J., Mallampalli R.Surfactants and its role in the pathology of pulmonary infection. Microbes Infect.2012; 14 (1): 17—25.
(check this in PDF content)
18
Calfee C.S., Ware L.B., Glidden D.V., Eisner M.D., Parsons P.E., Thompson B.T., Matthay M.A.Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit. Care Med.2011; 39 (4): 711—717.
(check this in PDF content)
19
Doyle I.R., Bersten A.D., Nicholas T.E. Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure. Am. J. Resp. Crit. Care Med.1997; 156 (4 Pt 1): 1217—1229.
(check this in PDF content)
20
Wu T.T., Chen T.L., Loon W.S., Tai Y.T., Cherng Y.G., Chen R.M. Lipopolysaccharide stimulates syntheses of toll-like receptor 2 and surfactant protein-A in human alveolar epithelial A549 cells through upregulating phosphorylation of MEK1 and ERK1/2 and sequential activation of NF-кB. Cytokine.2011; 55 (1): 40—47.
(check this in PDF content)
21
Gnadt M., Kardziev B., Schmidt M., Högger P. Surfactant protein A (SP-A) and angiotensin converting enzyme (ACE) as early biomarkers for pulmonary edema formation in ventilated human lung lobes. Lung.2012; 190 (4): 431—440.
(check this in PDF content)
22
Eisner M., Parsons P., Matthay M., Ware L., Greene K. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax.2003; 589 (11): 983—988.
(check this in PDF content)
23
Greene K., Wright J., Steinberg K., Ruzinski J., Caldwell E., Wong W., Hull W., Whitsett J., Akino T., Kuroki Y., Nagae H., Hudson L., Martin T. Serial changes of surfactant-associated proteins in lung and serum before and after onset of ARDS. Am. J. Respir. Crit. Care Med.1999; 160 (6): 1843—1850.
(check this in PDF content)
24
Cross L., Matthay M.Biomarkers of acute lung injury: insights into the pathogenesis pf acute lung injury. Crit. Care Clin.2011; 27 (2): 355—377.
(check this in PDF content)
25
Wright J.R.Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol.2005; 5 (1): 58—68.
(check this in PDF content)
26
Pastva A.M., Wright J.R., Williams K.L. Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc. Am. Thorac. Soc.2007; 4 (3): 252—257.
(check this in PDF content)
27
Lin P.M., Wright J.R.Surfactant protein A binds to IgG and enhances phagocytosis of IgG-opsonized erythrocytes. Am. J. Physiol. Lung Cell Mol. Physiol.2006; 291 (6): L1199—L1206.
(check this in PDF content)
28
Goto H., Ledford J.G., Mukherjee S., Noble P.W., Williams K.L., Wright J.R. The role of surfactant protein A in bleomycin-induced acute lung injury. Am. J. Resp. Crit. Care Med.2010; 181 (12): 1336—1344.
(check this in PDF content)
29
Mukherjee S., Giamberardino C., Thomas J., Evans K., Goto H., Ledford J.G., Hsia B., Pastva A.M., Wright J.R. Surfactant protein A integrates activation signal strength to differentially modulate T cell proliferation. J. Immunol. 2012; 188 (3): 957—967.
(check this in PDF content)
30
Henning L.N., Azad A.K., Parsa K.V., Crowther J.E., Tridandapani S., Schlesinger L.S.Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. J. Immunol.2008; 180 (12): 7847—7858.
(check this in PDF content)
31
Kovach M.A., Standiford T.J.Toll like receptors in diseases of the lung. Int. Immunopharmacol. 2011; 11 (10): 1399—1406.
(check this in PDF content)
32
Cheng I.W., Ware L.B., Greene K.E., Nuckton T.J., Eisner M.D., Matthay M.A. Prognostic value of surfactant protein a and D in patients with acute lung injury. Crit. Care Med.2003; 31 (1): 20—27.
(check this in PDF content)